SCHEMBL891196

SCHEMBL891196

CCCc1ccc(CC)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.38
EPAS1 Q99814 2/20 0.38
MPO P05164 1/20 0.38
TPO P07202 1/20 0.38
TSHR P16473 1/20 0.38
LPO P22079 1/20 0.38
CYP2C19 P33261 1/20 0.38
TAS2R38 P59533 1/20 0.38
GPR84 Q9NQS5 3/20 0.35
ADORA1 P30542 2/20 0.33
ADORA2A P29274 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
TP53 P04637 1/20 0.32
KDM5A P29375 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891184 0.92 HIF1A (0.42) HIF1AEPAS1MPOTPOTSHR
SCHEMBL890877 0.86
SCHEMBL28074189 0.83 TP53 (0.38) HIF1AEPAS1GPR84TAAR1TP53
SCHEMBL27763216 0.83 TP53 (0.38) HIF1AEPAS1GPR84TAAR1TP53
SCHEMBL17156494 0.82 HIF1A (0.50) HIF1AEPAS1MPOTPOTSHR
SCHEMBL2316961 0.77
SCHEMBL891270 0.76 HIF1A (0.53) HIF1AEPAS1GPR84MAPTHTT
SCHEMBL14754136 0.74
SCHEMBL490816 0.74 HIF1A (0.62) HIF1AEPAS1GPR84MAPTHTT
Pyrrole SCHEMBL28167023 0.74 TP53 (0.38) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US claimed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US claimed
WO-2025106415-A1 ETHYLENE TRIMERIZATION CATALYST SYSTEMS CONTAINING AROMATIC SOLVENTS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-05-22 WO disclosed
US-20250162963-A1 ETHYLENE TRIMERIZATION CATALYST SYSTEMS CONTAINING AROMATIC SOLVENTS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-05-22 US disclosed
EP-4359382-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS Chevron Phillips Chemical Company LP (US) 2024-05-01 EP disclosed
CN-117881658-A Two-step synthesis of pyrrole compounds from furan compounds 切弗朗菲利浦化学公司 2024-04-12 CN disclosed
US-11608317-B2 Two-step synthesis of pyrrole compounds from furan compounds CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2023-03-21 US disclosed
US-20220298109-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2022-09-22 US disclosed
WO-2022197944-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2022-09-22 WO disclosed
EP-2791091-B1 PREPARATION OF CHROMIUM(III) CARBOXYLATES CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-09-19 EP disclosed
EP-2930179-B1 RUTHENIUM COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM TOSOH CORP (JP) 2018-09-05 EP disclosed
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US disclosed
CN-102869445-A Oligomerization catalyst system and process for oligomerizing olefins CHEVRON PHILLIPS CHEMICAL CO 2013-01-09 CN disclosed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US disclosed
WO-2011137027-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-11-03 WO disclosed
CN-102164672-A Oligomerization catalyst system and process for oligomerizing olefins CHEVRON PHILLIPS CHEMICAL CO 2011-08-24 CN disclosed
EP-2349562-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS Chevron Phillips Chemical Company LP (US) 2011-08-03 EP disclosed
US-20100274065-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2010-10-28 US disclosed
US-20100113852-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2010-05-06 US disclosed
WO-2010051415-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250162963-A1 ETHYLENE TRIMERIZATION CATALYST SYSTEMS CONTAINING AROMATIC SOLVENTS NOD2, EXOC4, AHR HIF1A 3709/4885EPAS1 1449/4885MPO 1228/4885
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE PAH, CPS1, ASNS HIF1A 2563/4885EPAS1 4625/4885MPO 388/4885
US-11608317-B2 Two-step synthesis of pyrrole compounds from furan compounds DDC, DHPS, ACMSD HIF1A 2718/4885EPAS1 4431/4885MPO 1265/4885
US-20100274065-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS DHPS, PPOX, HPD HIF1A 4136/4885EPAS1 2688/4885MPO 1373/4885
US-20100113852-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS DHPS, COG5, PPOX HIF1A 4687/4885EPAS1 1791/4885MPO 1223/4885
US-20220298109-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS DDC, DHPS, ACMSD HIF1A 2718/4885EPAS1 4431/4885MPO 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.